<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Allos Therapeutics Inc. | Company News & Executive Profiles - ALTH | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/allos+therapeutics+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Allos Therapeutics Inc.]]></description>
	<s:counts start="0" returned="10" found="11" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Allos Therapeutics, Inc., Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-360443.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions Your first question comes from Mark Monane with Needham & Company. Mark Monane, M.D. - Needham & Company It is 5:00 here and it is already quite dark and that is something new for us on the East Coast.  Speaking of being in...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 03 Nov 2009 19:04:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/physician.html"><![CDATA[Physician]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/health+care+company.html"><![CDATA[Health Care Company]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/allos+therapeutics+inc..html"><![CDATA[Allos Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/distribution+channel.html"><![CDATA[Distribution Channel]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALTH</category>
		<category domain="tickers">ALTH</category>
	</item>
	<item>
		<title><![CDATA[Market Jitters Affect Allos]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F160156-market-jitters-affect-allos%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[EP Vantage submits: Usually the endorsement of an FDA advisory panel for approval of your product is greeted with praise from analysts and an uplift in share price. Unfortunately for Allos Therapeutics ALTH, their 10-4 positive recommendation for pralatrexate, now known as Folotyn, for the hard-to-treat blood cancer, peripheral T-cell...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 06 Sep 2009 04:08:26 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ep+vantage.html"><![CDATA[EP Vantage]]></category>
		<category domain="http://resources.bnet.com/topic/allos+therapeutics+inc..html"><![CDATA[Allos Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALTH</category>
		<category domain="tickers">ALTH</category>
	</item>
	<item>
		<title><![CDATA[Allos Therapeutics: Prospects for FDA Approval of Folotyn Are Healthy]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F159976-allos-therapeutics-prospects-for-fda-approval-of-folotyn-are-healthy%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[After announcing  that  the U.S.       Food and Drug Administration&#8217;s [FDA] Oncologic Drugs Advisory Committee [ODAC] voted 10-4 that the response rate and duration of response       observed with FOLOTYNTM pralatrexate are reasonably likely to predict clinical benefit...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 04 Sep 2009 02:47:45 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/m.+e.+garza.html"><![CDATA[M. E. Garza]]></category>
		<category domain="http://resources.bnet.com/topic/allos+therapeutics+inc..html"><![CDATA[Allos Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALTH</category>
		<category domain="tickers">ALTH</category>
	</item>
	<item>
		<title><![CDATA[Allos Therapeutics: Smallcap Biotech with FDA Catalyst]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F133294-allos-therapeutics-smallcap-biotech-with-fda-catalyst%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Allos Therapeutics ALTH is small-cap cancer biotech which filed a NDA on 3/25/09 for pralatrexate (PDX) in the treatment of patients with relapsed/refractory peripheral T-cell lymphoma (PTCL). ALTH requested priority (six-month) review for the application, with an expected 60-day period for the FDA to accept the filing...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 27 Apr 2009 02:04:52 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/allos+therapeutics+inc..html"><![CDATA[Allos Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALTH</category>
		<category domain="tickers">ALTH</category>
	</item>
	<item>
		<title><![CDATA[FDA, Clinical Trial Calendar Updates: Thoratec, Allos Therapeutics]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F131946-fda-clinical-trial-calendar-updates-thoratec-allos-therapeutics%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Below is a summary of updates to the BioMedReports.com database of over 200 entries included in the FDA and Clinical Trial Calendars. The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 21 Apr 2009 01:43:04 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/allos+therapeutics+inc..html"><![CDATA[Allos Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/thoratec+corp..html"><![CDATA[Thoratec Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALTH</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">THOR</category>
		<category domain="tickers">ALTH,THOR</category>
	</item>
	<item>
		<title><![CDATA[Allos Therapeutics, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-279942.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. Operator instructions. One moment please for your first question. Our first question comes from the line of Mark Monane with Needham & Company. Please go ahead. Mark Monane &#8211; Needham & Company Thank you. Good afternoon from a cold but &#8211; and still a little...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 19 Mar 2009 07:41:20 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/response.html"><![CDATA[Response]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/needham+%2526+co..html"><![CDATA[Needham & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/allos+therapeutics+inc..html"><![CDATA[Allos Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALTH</category>
		<category domain="tickers">ALTH</category>
	</item>
	<item>
		<title><![CDATA[Allos Therapeutics Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-246749.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions.  Your first question comes from Katherine Kim &#8211; Banc of America Securities.   Katherine Kim &#8211; Banc of America Securities  The first is the ASH abstracts which should be available soon.  Do you expect to have any incremental or information in...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 05 Nov 2008 20:28:11 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/response.html"><![CDATA[Response]]></category>
		<category domain="http://resources.bnet.com/topic/abstract.html"><![CDATA[Abstract]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/banc+of+america+securities.html"><![CDATA[Banc Of America Securities]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/allos+therapeutics+inc..html"><![CDATA[Allos Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/response.html"><![CDATA[Response]]></category>
		<category domain="http://resources.bnet.com/topic/abstract.html"><![CDATA[Abstract]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/banc+of+america+securities.html"><![CDATA[Banc Of America Securities]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/allos+therapeutics+inc..html"><![CDATA[Allos Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALTH</category>
		<category domain="tickers">ALTH</category>
	</item>
	<item>
		<title><![CDATA[Allos Therapeutics, Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-223463.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Thank you, sir. Ladies and gentlemen, we will now begin the question-and-answer session. Operator instructions Our first question comes from the line of Lucy Lu with Citi group. Please go ahead.  Lucy Lu &#8211; Citigroup  Great. Thank you. Actually can you just please...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 08 Sep 2008 19:17:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/allos+therapeutics+inc..html"><![CDATA[Allos Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALTH</category>
		<category domain="tickers">ALTH</category>
	</item>
	<item>
		<title><![CDATA[Allos Therapeutics Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-226496.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions The first question comes from Mr. Mark Monane. Please state your company name followed by your question. Mark Monane - Needham & Company Thank you. Good morning. It's Mark Monane from Needham & Company. Good morning from New York City. Paul Berns Good morning,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 26 May 2008 14:58:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/allos+therapeutics+inc..html"><![CDATA[Allos Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALTH</category>
		<category domain="tickers">ALTH</category>
	</item>
	<item>
		<title><![CDATA[Allos Therapeutics, Inc Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-228584.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions. Our first question comes from the line of Mark Monane with Needham & Company. Please go ahead.  Mark Monane &#8211; Needham & Company  Good morning and thank you for taking my questions. Regards from New York City. Paul Berns Hi Mark. Mark...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 17 Apr 2008 07:15:25 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/allos+therapeutics+inc..html"><![CDATA[Allos Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALTH</category>
		<category domain="tickers">ALTH</category>
	</item>
</channel>
</rss>
